Wegovy vs Ozempic
They are the same drug — semaglutide — approved for different things. Here is how cost, dosing, weight-loss results, and side effects actually compare in 2026.
Wegovy and Ozempic are both semaglutide made by Novo Nordisk, but with different FDA-approved uses. Ozempic treats type 2 diabetes (up to 2 mg weekly); Wegovy is approved for weight loss (up to 2.4 mg, plus a 7.2 mg HD dose). Wegovy showed ~14.9% weight loss in trials; Ozempic less, because its dose is lower. Cash prices are similar — about $349/month each via NovoCare. Confirm pricing with the provider. This is information, not medical advice.
Last updated: June 2026 • 10 min read
Wegovy vs Ozempic at a Glance (2026)
| Factor | Wegovy | Ozempic |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Maker | Novo Nordisk | Novo Nordisk |
| FDA-approved use | Chronic weight management; cardiovascular-risk reduction; MASH | Type 2 diabetes; cardiovascular-risk reduction in T2D + heart disease |
| Approved for weight loss? | Yes — this is its primary indication | No — used off-label by some clinicians |
| Dose range (weekly) | 0.25 → 2.4 mg (plus 7.2 mg Wegovy HD) | 0.25 → 2 mg |
| Trial weight loss | ~14.9% at 2.4 mg (STEP 1); 20.7% at 7.2 mg (STEP UP) | ~5-6 kg in diabetes trials (SUSTAIN) |
| Cash price (standard dose) | ~$349/mo via NovoCare self-pay | ~$349/mo via NovoCare self-pay |
| List price (no discount) | ~$1,349/mo (Novo Nordisk WAC) | ~$1,027/mo (Novo Nordisk WAC) |
Prices are advertised 2026 cash rates and change frequently. Confirm current pricing, dose, and eligibility directly with the manufacturer or pharmacy. Trial figures are group averages from published studies, not individual guarantees. See the full GLP-1 weight-loss guide for the underlying science.
Same Molecule, Different Label
The single most important thing to understand: Wegovy and Ozempic are the same active drug, semaglutide, from the same company, Novo Nordisk. They are not competitors in the chemistry — they are two labels on one molecule, separated by what the FDA approved each one to treat and how high the dose goes.
- Ozempic is approved to improve blood sugar in adults with type 2 diabetes and to reduce the risk of major cardiovascular events in people with type 2 diabetes and known heart disease. Its weekly dose tops out at 2 mg.
- Wegovy is approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a weight-related condition, plus cardiovascular-risk reduction and, more recently, MASH (a liver condition). Its standard dose goes to 2.4 mg, and a higher 7.2 mg Wegovy HD dose was FDA-approved in March 2026.
Because they share a molecule, people often ask whether they can take Ozempic for weight loss. Some clinicians do prescribe it off-label, but Wegovy is the version actually approved for that purpose — and the one studied at the higher doses that drive larger weight loss.
Cost: Wegovy vs Ozempic in 2026
On paper the two list prices differ — Wegovy is the more expensive sticker — but very few cash patients pay full list. The number that matters for someone paying out of pocket is the manufacturer's direct self-pay price, and there the two are nearly identical.
- List price. Per Novo Nordisk's published pricing, Wegovy's list price (wholesale acquisition cost) is about $1,349/month and Ozempic's is about $1,027/month. Novo Nordisk has announced a list-price reduction for both medicines beginning January 2027.
- NovoCare self-pay (cash). Through Novo Nordisk's direct program, standard doses of either drug run about $349/month. Wegovy HD (7.2 mg) is about $399; Ozempic 2 mg is about $499. New patients have seen introductory first-fills as low as ~$199 for the lowest doses.
- With commercial insurance. Eligible commercially insured patients may pay as little as $25/month via the manufacturer savings card, subject to a monthly cap. Government-insured patients (Medicare, Medicaid) are excluded from those savings cards.
Note: Coverage is the biggest swing factor. Many plans cover Ozempic for diabetes but not Wegovy for weight loss, or require prior authorization. The cash prices above are advertised 2026 figures that change — confirm the current price and your coverage with the pharmacy, manufacturer, and your insurer before you commit.
If you are weighing the broader market — brand semaglutide, compounded versions, and the telehealth programs that bundle the prescription with coaching — start with our Hims vs Ro vs Calibrate comparison and the compounded semaglutide guide.
Dosing: How They Differ
Both drugs are once-weekly subcutaneous injections that start low and titrate up to let the body adjust and reduce side effects. The key difference is the ceiling.
- Ozempic starts at 0.25 mg weekly and increases to a maintenance dose of up to 2 mg.
- Wegovy starts at 0.25 mg and steps up to 2.4 mg, with a higher 7.2 mg Wegovy HD option approved in March 2026 for people who need more weight reduction than the standard dose provides.
That higher Wegovy ceiling is why Wegovy, not Ozempic, is the version associated with the largest weight-loss numbers. Titration schedules are set by a clinician — do not accelerate doses on your own.
Weight-Loss Results: What the Trials Show
Direct trial numbers tell the story better than marketing claims. These are group averages from published studies, with lifestyle changes alongside the drug — individual results vary widely.
- Wegovy 2.4 mg (STEP 1 trial): adults lost about 14.9% of body weight over 68 weeks, versus 2.4% on placebo.
- Wegovy HD 7.2 mg (STEP UP trial): mean weight loss of 20.7%, with roughly one in three participants reaching 25% or more.
- Ozempic (SUSTAIN diabetes trials): weight loss was smaller — on the order of 5-6 kg — because the dose is lower and the trials were in people with type 2 diabetes, who tend to lose less weight on GLP-1s.
The practical read: if the primary goal is weight loss and you qualify, Wegovy is the on-label, higher-dose option with the larger published results. Ozempic's strength is glycemic control in type 2 diabetes. Neither is a guarantee, and both are intended as long-term treatments — studies show weight regain is common after stopping.
Side Effects: Largely the Same
Because they are the same molecule, Wegovy and Ozempic share a side-effect profile that is mostly gastrointestinal and usually most noticeable during dose increases:
- Nausea and occasional vomiting
- Diarrhea or constipation
- Stomach pain and bloating
These often ease over time as the body adjusts. Both medications also carry an FDA boxed warning about thyroid C-cell tumors observed in rodent studies, and both should be avoided by people with a personal or family history of medullary thyroid carcinoma or MEN 2. Rarer but serious risks discussed in the labeling include pancreatitis and gallbladder problems.
Side effects and contraindications are individual. This guide summarizes published, general information — it is not a substitute for a clinician reviewing your full history before prescribing.
Which One Fits Your Goal?
Best for weight loss
- ✓Wegovy — FDA-approved for chronic weight management, higher dose ceiling, larger trial results
- ✓Wegovy HD (7.2 mg) for those who need more than the standard dose, under clinician guidance
Best for type 2 diabetes
- ✓Ozempic — FDA-approved for blood-sugar control and cardiovascular-risk reduction in T2D
- ✓Often the better-covered option when the diagnosis is diabetes rather than obesity
Before you commit to either, confirm a few practical points:
- Which drug does my insurance actually cover, and is a prior authorization needed?
- What is the real out-of-pocket cost — savings card, NovoCare self-pay, or list?
- Do I have a diagnosis that makes one the on-label choice?
- What is the long-term plan, given that stopping often leads to weight regain?
Frequently Asked Questions
Are Wegovy and Ozempic the same drug?▼
Both contain the same active ingredient, semaglutide, and are made by Novo Nordisk. The difference is the FDA-approved use and the maximum dose. Ozempic is approved to treat type 2 diabetes (and to lower cardiovascular risk in people with type 2 diabetes and heart disease) at up to 2 mg weekly. Wegovy is approved for chronic weight management at up to 2.4 mg weekly, with a 7.2 mg Wegovy HD dose approved in March 2026. They are the same molecule used for different goals.
Is Wegovy or Ozempic cheaper without insurance?▼
They are priced almost identically through Novo Nordisk’s NovoCare self-pay program. As of 2026, standard doses run about $349 per month for either drug, and the highest standard doses run about $399 (Wegovy HD) to $499 (Ozempic 2 mg). List prices are far higher — Novo Nordisk lists Wegovy at about $1,349 and Ozempic at about $1,027 per month — but few cash patients pay full list, and Novo has announced a list-price cut for both starting January 2027. These are advertised prices that change; confirm the current cash price directly with the pharmacy or manufacturer.
Can I take Ozempic for weight loss?▼
Ozempic is FDA-approved to treat type 2 diabetes, not for weight loss. Some clinicians prescribe it off-label for weight reduction because it contains the same semaglutide as Wegovy, but Wegovy is the version FDA-approved specifically for chronic weight management. Whether a given prescription is appropriate — and whether insurance will cover it — depends on your diagnosis. Discuss the right option for you with a licensed clinician.
How much weight do you lose on Wegovy vs Ozempic?▼
In the STEP 1 trial, adults on Wegovy 2.4 mg lost about 14.9% of body weight over 68 weeks versus 2.4% on placebo, both with lifestyle changes. The newer Wegovy HD 7.2 mg dose showed 20.7% mean weight loss in the STEP UP trial. Ozempic’s diabetes trials (SUSTAIN) showed smaller weight loss — roughly 5-6 kg — because the dose tops out at 2 mg. Individual results vary; these are trial averages, not guarantees.
What are the side effects of Wegovy and Ozempic?▼
Because both are semaglutide, the side-effect profile is similar and mostly gastrointestinal: nausea, vomiting, diarrhea, constipation, and stomach pain or bloating. These are usually most noticeable when the dose is being increased and often ease over time. Both carry a boxed warning about thyroid C-cell tumors seen in rodents. This is general information, not medical advice — review your personal risks with a clinician.
Do you regain weight if you stop semaglutide?▼
Both Wegovy and Ozempic are intended as long-term treatments, and studies show people tend to regain weight after stopping. Semaglutide works while it is in your system; it is not a one-time cure. Plan with your clinician for what maintenance looks like — whether that means staying on a dose, tapering, or building durable nutrition and training habits. This is information, not a treatment plan.
Compare GLP-1 Weight-Loss Options
See cash-pay weight-loss programs, telehealth providers, and what each actually charges.
Explore Weight-Loss Options →Related Guides
Sources
- • NovoCare — Wegovy cost, coverage & savings
- • NovoCare — Ozempic self-pay price guide
- • Novo Nordisk — Wegovy HD (7.2 mg) approved, 20.7% mean weight loss
- • AJMC — Semaglutide 2.4 mg (STEP 1): ~14.9% weight loss
- • Medical News Today — Ozempic vs Wegovy differences
- • Novo Nordisk — Ozempic list price (WAC ~$1,027/mo)
- • Novo Nordisk — Wegovy list price (WAC ~$1,349/mo)
- • DailyMed (FDA) — Wegovy prescribing information & boxed warning (thyroid C-cell tumors)
Medical disclaimer: This page is general information, not medical advice. Listings are aggregated from public sources and prices are estimates that may be out of date — confirm current pricing, services, and provider credentials directly with each clinic. Talk to a licensed clinician before starting any medication or treatment.
Affiliate disclosure: VitalityScout may earn a commission from some links, at no additional cost to you. This never affects which providers we list or how we describe them.
Comparing GLP-1 Options?
Get our cash-pay GLP-1 price comparison plus tips for choosing between Wegovy, Ozempic, and the telehealth programs.
No spam, unsubscribe anytime.